{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 788, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/IdOdFebfItAKPxMaQbYLgALkTPk74yedGtBNo3z2LRs/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85MWQwYTI2ZTEwZTNjNDFkL3AwMDEuanBn", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/1", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/pX7QF3ZdCxf_wkxbPzhKN7HWW4Ls7gVNtmuWAtWXQNA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85MWQwYTI2ZTEwZTNjNDFkL3AwMDEucG5n", "thumbSrc": "https://imgproxy.kitesheet.com/2toBut80DCc6086SqarNZcP4Xh7dfEVwFX5sxdhC7x0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85MWQwYTI2ZTEwZTNjNDFkL3AwMDEuanBn", "thumbSrcAlt": "https://imgproxy.kitesheet.com/aHBATMhSorMAhwjMW_KnacjN1MHFvm2GG8Vwmfh9y78/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85MWQwYTI2ZTEwZTNjNDFkL3AwMDEucG5n" }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/2", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 3, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a chevron-based timeline to illustrate strategic evolution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/3", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 4, "slideType": "kpi_dashboard", "function": "summarize", "notes": "The slide uses a 3x3 grid structure to present key performance indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/4", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 5, "slideType": "comparison_table", "function": "compare_options", "notes": "Uses a 'From... To...' comparison framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/5", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 6, "slideType": "kpi_dashboard", "function": "quantify_impact", "notes": "The chart tracks performance over rolling three-year periods from 2016-2018 through 2020-2022, with a final column indicating the most recent performance exceeding the $1Tn target.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/6", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 7, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a simple three-column layout to present high-level strategic targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/7", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 8, "slideType": "customer_journey", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/8", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 9, "slideType": "financial_analysis", "function": "quantify_impact", "notes": "The chart uses a waterfall structure to bridge the gap between current and future assets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/9", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 10, "slideType": "financial_analysis", "function": "quantify_impact", "notes": "The slide uses a classic waterfall bridge structure to explain the delta between current and future financial performance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/10", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 11, "slideType": "appendix", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/11", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 12, "slideType": "appendix_disclosure", "function": "appendix", "notes": "This slide provides technical definitions for terms like WM Client Assets, Fee-Based Assets, Client Relationships, NNA, and peer comparison methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/12", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 13, "slideType": "appendix_disclosure", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/13", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-315ef6fa8caf", "docSlug": "91d0a26e10e3c41d", "documentTitle": "2023.05.31 Bernstein Conference", "authorId": "GoldmanSachs", "authorName": "Morgan Stanley", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 14, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-315ef6fa8caf/14", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-315ef6fa8caf#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-28c72cc9d740", "docSlug": "1b9c53be021f8188", "documentTitle": "asset and wealth management mn", "authorId": "GoldmanSachs", "authorName": "Goldman Sachs", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 181, "slideType": "appendix_disclosure", "function": "other", "notes": "This is a standard regulatory disclosure document.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-28c72cc9d740/181", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740#slide-181", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-28c72cc9d740", "docSlug": "1b9c53be021f8188", "documentTitle": "asset and wealth management mn", "authorId": "GoldmanSachs", "authorName": "Goldman Sachs", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 182, "slideType": "appendix_disclosure", "function": "appendix", "notes": "This is a standard legal disclosure page from an ERISA or investment advisory presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-28c72cc9d740/182", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740#slide-182", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-28c72cc9d740", "docSlug": "1b9c53be021f8188", "documentTitle": "asset and wealth management mn", "authorId": "GoldmanSachs", "authorName": "Goldman Sachs", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 183, "slideType": "appendix_disclosure", "function": "other", "notes": "This is a standard legal disclosure page, likely part of a larger document set.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-28c72cc9d740/183", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-28c72cc9d740#slide-183", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/hVoscs9elBj8V6pU1v-pGnXiI1AO1pvLRq9SJdFHbGA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDM1NDVhNmMwMTBkN2NiL3AwMDEuanBn", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/1", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/caSPpgyY1Xy-eg-0TJd7zXDtcH0Ck7K7j3pE-HQGZ1o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDM1NDVhNmMwMTBkN2NiL3AwMDEucG5n", "thumbSrc": "https://imgproxy.kitesheet.com/ZV3xMH4SaNm8lSRbLUZF3X3jb47azX1SLH_NeSMRWSA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDM1NDVhNmMwMTBkN2NiL3AwMDEuanBn", "thumbSrcAlt": "https://imgproxy.kitesheet.com/zAkGtsJHsa5t6KhWYCtF3UEaBqrLBI1PU1YE68amrSE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy82ZDM1NDVhNmMwMTBkN2NiL3AwMDEucG5n" }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/2", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a list of callout boxes to highlight key company milestones and financial status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/3", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 4, "slideType": "roadmap", "function": "present_solution", "notes": "The slide uses a timeline-based visualization to show the status of drug development programs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/4", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 5, "slideType": "problem_statement", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/5", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 6, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a horizontal process-like flow to present key metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/6", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 7, "slideType": "other", "function": "present_solution", "notes": "The slide emphasizes the bioerodible nature and small size of the insert compared to legacy technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/7", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 8, "slideType": "other", "function": "present_solution", "notes": "The slide explains the mechanism of action (Vorolanib) and the delivery technology (Durasert E) for the product DURAVYU.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/8", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 9, "slideType": "case_study", "function": "illustrate_case", "notes": "The slide uses a table-like structure to map clinical trials (DAVIO, DAVIO 2, PAVIA, VERONA) to patient counts and key outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/9", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 10, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/10", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 11, "slideType": "business_case", "function": "present_solution", "notes": "The slide uses a four-column layout to present strategic advantages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/11", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 12, "slideType": "data_table", "function": "quantify_impact", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/12", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 13, "slideType": "timeline", "function": "present_framework", "notes": "Includes a callout box regarding LUGANO enrollment status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/13", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 14, "slideType": "timeline", "function": "summarize", "notes": "The slide uses a timeline framework to track trial progress from Jan 2025 to mid-2026.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/14", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 15, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo and copyright information.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/15", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 16, "slideType": "comparison_table", "function": "compare_options", "notes": "The slide uses a timeline-based visual to contrast injection frequency across five different pharmaceutical products.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/16", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 17, "slideType": "case_study", "function": "illustrate_case", "notes": "The slide uses a timeline-based study design framework.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/17", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 18, "slideType": "case_study", "function": "illustrate_case", "notes": "The slide uses a split-layout with a summary/thesis on the left and specific trial results on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/18", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 19, "slideType": "case_study", "function": "illustrate_case", "notes": "The chart compares DURAVYU 2.7mg, 1.3mg, and aflibercept 2mg. A red box highlights the early improvement at Week 4.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/19", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 20, "slideType": "data_table", "function": "quantify_impact", "notes": "The outlier patient missed multiple visits, leading to significant vision loss at week 24.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/20", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 21, "slideType": "data_table", "function": "quantify_impact", "notes": "The chart compares DURAVYU 2.7mg, DURAVYU 1.3mg, and Aflibercept 2mg. The final values at Week 24 are highlighted in a box.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/21", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 22, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo and copyright/disclaimer footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/22", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 23, "slideType": "data_table", "function": "quantify_impact", "notes": "Supplement-free is defined as patients who did not receive a supplement at any point during the study.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/23", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 24, "slideType": "case_study", "function": "illustrate_case", "notes": "The slide uses a timeline to show the transition from standard-of-care anti-VEGF injections to the DURAVYU treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/24", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 25, "slideType": "case_study", "function": "illustrate_case", "notes": "The slide uses a timeline to show prior SOC injections followed by the DURAVYU treatment and subsequent follow-up.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/25", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 26, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/26", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-26", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 27, "slideType": "other", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/27", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 28, "slideType": "timeline", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/28", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-2e760724f3df", "docSlug": "6d3545a6c010d7cb", "documentTitle": "Eyepoint Goldman Sachs June 10 2025", "authorId": "GoldmanSachs", "authorName": "EyePoint Pharmaceuticals", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 29, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-2e760724f3df/29", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-2e760724f3df#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/NjHiT8W1nPBKfTKmdzh1pxQc-spicXJ6FMA8zPporW0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjhiMGIyMmIzYTgyMzA3L3AwMDEuanBn", "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/1", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "6e7dd8d3-d1b1-447e-95e3-7a7b7725aee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and appendix disclosure grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/HsAjIB662eMBnIplAmz3xBxilkR9dkWIzQPYNxjM16c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjhiMGIyMmIzYTgyMzA3L3AwMDEucG5n", "thumbSrc": "https://imgproxy.kitesheet.com/1wUjJwq74DhCBwsKeIowH01LUYf_ydIo4pQ3htOxK1M/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjhiMGIyMmIzYTgyMzA3L3AwMDEuanBn", "thumbSrcAlt": "https://imgproxy.kitesheet.com/REFlj7nEmsUDXNhiacP-PoOFTlptadnMOOwumAKQpDM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjhiMGIyMmIzYTgyMzA3L3AwMDEucG5n" }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/2", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 2, "from": 1, "beatId": "6e7dd8d3-d1b1-447e-95e3-7a7b7725aee2", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The cover slide and appendix disclosure grab the audience's attention.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 3, "slideType": "situation_overview", "function": "establish_context", "notes": "The slide uses a three-column layout to categorize business operations by geographic scope (Regional, National, International) with corresponding maps.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/3", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-3", "loopMatches": [ { "to": 5, "from": 3, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "71a928ce-806d-4b4b-8994-515f27bf75b6", "evidence": "The situation overview and peer benchmark slides logically lead to the growth opportunities discussed later.", "position": 0, "objective": "Understand U.S. Bancorp's position and growth opportunities", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "67a72ced-1a3a-4a29-98f6-66cc3f6f7f8f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The situation overview and peer benchmark slides establish the need for growth.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 4, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "U.S. Bancorp is highlighted in each column to show its relative rank.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/4", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-4", "loopMatches": [ { "to": 5, "from": 3, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "71a928ce-806d-4b4b-8994-515f27bf75b6", "evidence": "The situation overview and peer benchmark slides logically lead to the growth opportunities discussed later.", "position": 0, "objective": "Understand U.S. Bancorp's position and growth opportunities", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "67a72ced-1a3a-4a29-98f6-66cc3f6f7f8f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The situation overview and peer benchmark slides establish the need for growth.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 5, "slideType": "segmentation", "function": "decompose_segments", "notes": "The slide uses a pie chart to illustrate the revenue contribution of four main business lines.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/5", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-5", "loopMatches": [ { "to": 5, "from": 3, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "71a928ce-806d-4b4b-8994-515f27bf75b6", "evidence": "The situation overview and peer benchmark slides logically lead to the growth opportunities discussed later.", "position": 0, "objective": "Understand U.S. Bancorp's position and growth opportunities", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "67a72ced-1a3a-4a29-98f6-66cc3f6f7f8f", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The situation overview and peer benchmark slides establish the need for growth.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 6, "slideType": "initiative_list", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/6", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 7, "slideType": "kpi_dashboard", "function": "analyze_data", "notes": "Includes data tables for volume composition and line charts for monthly sales volume growth relative to 2019.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/7", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 8, "slideType": "industry_trends", "function": "quantify_impact", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/8", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 9, "slideType": "market_landscape", "function": "size_opportunity", "notes": "Includes two pie charts for relationship segmentation and a bar chart for talech customer growth.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/9", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 10, "slideType": "client_example", "function": "illustrate_case", "notes": "The slide uses a split-screen comparison layout to showcase two distinct product offerings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/10", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 11, "slideType": "client_example", "function": "illustrate_case", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/11", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 12, "slideType": "business_case", "function": "illustrate_case", "notes": "Includes pro-forma financial charts comparing USB standalone vs combined entity, and a table of branch footprints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/12", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 13, "slideType": "other", "function": "summarize", "notes": "The slide uses an ESG framework to categorize corporate responsibility efforts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/13", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5e88-73ef-bd5a-34bb3065e685", "docSlug": "4f8b0b22b3a82307", "documentTitle": "Goldman Sachs Presentation Final", "authorId": "GoldmanSachs", "authorName": "U.S. Bancorp", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "equity_research", "sourceTypeLabel": "Equity research", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 14, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5e88-73ef-bd5a-34bb3065e685/14", "deckHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685", "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-34bb3065e685#slide-14", "loopMatches": [ { "to": 14, "from": 14, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "3ecf6a49-a6ce-4c20-84c1-4e2dd53e585b", "evidence": "The key messages slide provides context for U.S. Bancorp's strong position heading into 2022.", "position": 1, "objective": "Explain why U.S. Bancorp is well-positioned for growth now", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.6, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 6, "beatId": "28e5b45f-9f9a-47d3-a863-a045586a0f8b", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The initiative list, KPI dashboard, and key messages satisfy the audience's need for growth opportunities.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }